Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome

Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses

(2011) Corinne M. Spencer et al.   Autism Research

Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA/2J mice

(2010) Hirohiko Hikichi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Mechanism-based approaches to treating fragile X

(2010) Gül Dölen et al.   PHARMACOLOGY & THERAPEUTICS

Characterization of the selective mGluR1 antagonist, JNJ16259685, in rodent models of movement and coordination

(2010) Robert A. Hodgson et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Fragile X syndrome: from molecular genetics to therapy

(2009) C D'Hulst et al.   JOURNAL OF MEDICAL GENETICS

Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety

(2009) Alexia Thomas et al.   PSYCHOPHARMACOLOGY

Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene.

(2008) Richard Paylor et al.   BEHAVIORAL NEUROSCIENCE

Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice

(2008) Femke M.S. de Vrij et al.   NEUROBIOLOGY OF DISEASE

Advances in the Treatment of Fragile X Syndrome

(2008) R. J. Hagerman et al.   PEDIATRICS